Literature DB >> 23183407

Small cell carcinoma of the lung presented as acute pancreatitis. Case report and review of the literature.

Abdulzahra Hussain1, Ali Adnan, Shamsi El-Hasani.   

Abstract

CONTEXT: Small cell carcinoma of the lung is an aggressive cancer with gloomy prognosis. Links to acute pancreatitis is extremely rare. CASE REPORT: We are reporting a 53-year-old patient who was admitted because of acute pancreatitis. She had no history of gallstones, alcohol abuse, medications or any other predisposition for acute pancreatitis. Further investigations of blood, CT of chest abdomen and neck and ultrasound scan of abdomen, bone marrow and neck lymph node biopsies confirmed advanced small cell carcinoma of the lung with hypercalcemia, which was the only definite cause of acute pancreatitis. The patient made good recovery from pancreatitis after controlling the hypercalcemia. She was referred to respiratory team for further management of lung cancer.
CONCLUSION: Acute pancreatitis due to hypercalcemia of advanced small cell carcinoma of the lung is an extremely rare condition. Acute pancreatitis due to hypercalcemia should be thoroughly investigated to exclude serious pathology as in our case.

Entities:  

Mesh:

Year:  2012        PMID: 23183407     DOI: 10.6092/1590-8577/1181

Source DB:  PubMed          Journal:  JOP        ISSN: 1590-8577


  3 in total

Review 1.  Paraneoplastic syndromes associated with lung cancer.

Authors:  Nobuhiro Kanaji; Naoki Watanabe; Nobuyuki Kita; Shuji Bandoh; Akira Tadokoro; Tomoya Ishii; Hiroaki Dobashi; Takuya Matsunaga
Journal:  World J Clin Oncol       Date:  2014-08-10

2.  First report of small cell lung cancer with PTHrP-induced hypercalcemic pancreatitis causing disconnected duct syndrome.

Authors:  Eric M Montminy; Stephen W Landreneau; Jordan J Karlitz
Journal:  World J Clin Oncol       Date:  2017-10-10

Review 3.  Acute Pancreatitis: Diagnosis and Treatment.

Authors:  Peter Szatmary; Tassos Grammatikopoulos; Wenhao Cai; Wei Huang; Rajarshi Mukherjee; Chris Halloran; Georg Beyer; Robert Sutton
Journal:  Drugs       Date:  2022-09-08       Impact factor: 11.431

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.